RLMD
Relmada Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.30
+0.30 (+6.00%)
Rating:C
Company Profile
CEO
Sergio Traversa
IPO Date
2014-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$4.99
Prev. Close
$5.00
Day Low
$4.86
Day High
$5.43
52W Low
$0.55
52W High
$8.00
Market Cap
$0.56B
Volume
2.62M